Article Text

PDF
Thrombolysis beyond 3 hours for acute ischaemic stroke
  1. R Selvaratnam1,
  2. U Srirangalingam1,
  3. S Ahmad2,
  4. P Goulden1
  1. 1
    Maidstone General Hospital, Maidstone, Kent, UK
  2. 2
    King’s College Hospital, London, UK
  1. Correspondence to Dr R Selvaratnam, Department of Medicine, Hermitage Lane, Maidstone, Kent ME16 9QQ, UK; rselvaratnam{at}doctors.org.uk

Abstract

Intravenous thrombolysis is an accepted form of treatment for acute ischaemic stroke when administered within 3 h of symptom onset. However, evidence for its benefit when given beyond this time continues to strengthen. The case history of a young woman is presented with an ischaemic stroke who was successfully thrombolysed with recombinant tissue-type plasminogen activator more than 3 h after presentation. Perfusion CT scanning was used to stratify the likelihood of benefit. Thrombolysis was administered through a combination of intravenous and intra-arterial routes. This case illustrates the advances being made both in the imaging techniques used and the forms of drug administration which can be applied to maximise benefit in this extended therapeutic window. These recent advances are reviewed and their possible impact on current and future practice assessed. While the drive remains the introduction of thrombolysis at a local level for ischaemic stroke within 3 h of symptom onset, it is necessary to consider treatment of subjects presenting beyond 3 h in tertiary centres with the appropriate facilities and expertise.

Statistics from Altmetric.com

Footnotes

  • Funding None.

  • Competing interests None.

  • Patient consent Obtained.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.